πŸ‡ΊπŸ‡Έ FDA
Patent

US 6632808

Inhibitors of amyloid formation

expired A61KA61K31/409A61K31/555

Quick answer

US patent 6632808 (Inhibitors of amyloid formation) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
70
CPC classes
A61K, A61K31/409, A61K31/555